On ECHEMI
Home > Drugs > Sapropterin dihydrochloride Registered Holders
Sapropterin dihydrochloride structure

Sapropterin dihydrochloride structure

Sapropterin dihydrochloride

Sapropterin dihydrochloride is a synthetic form of BH4 that is approved for the treatment of BH4 responsive PKU. (1) Sapropterin dihydrochloride can stimulate TH and TPH activities leading to improved dopamine and serotonin synthesis despite persistently elevated brain phenylalanine.(2) Sapropterin dihydrochloride is used to lower blood phenylalanine levels in tetrahydrobiopterin-responsive phenylketonuria in conjunction with a phenylalanine-restricted diet.

Find 11 Related Holders

Hetero Pharma (Beijing) Co., Limited
China China

API Registration Country

API Inactive
  • Founded in:

    2019-07-19
  • Country:

    China China
  • Address:

    Room 2701, 27th Floor, Building 6, District 4, Wangjing East Park, Chaoyang District, Beijing
  • Tax NO.:

    91110105MA01LK9Q77
  • Registered Funds:

    $2.1 million
  • Email:

  • 1
  • 2
  • Go to Page Go
Recommended Suppliers of Sapropterin dihydrochloride
View 23 Suppliers Request for Quotation
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.